Gilead pressured to settle AIDS drug dispute with Brazil

07/6/2005 | San Francisco Bay Guardian, The

Gilead is negotiating with the Brazilian government over the U.S. firm's patent for Viread, considered a key drug in the fight against AIDS and one the government-run Farmanguinhos wants to copy in a much cheaper generic form. AIDS activists in the San Francisco area, where Gilead is headquartered, are pressing the company to reach an agreement with the Brazilian government, noting the firm offers the drug at cut-rate prices in Africa and other parts of Latin America.

View Full Article in:

San Francisco Bay Guardian, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX